Bruin Cll-321: A Phase 3 Open-Label, Randomized Study Of Pirtobrutinib Vs Investigator'S Choice Of Idelalisib+Rituximab Or Bendamustine+Rituximab In Btki Pretreated Cll/Sll (Trial In Progress)
Pirtobrutinib;Bendamustine;Idelalisib;Rituximab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Bruin Cll-321: A Phase 3 Open-Label, Randomized Study Of Pirtobrutinib Vs Investigator'S Choice Of Idelalisib+Rituximab Or Bendamustine+Rituximab In Btki Pretreated Cll/Sll (Trial In Progress) ### Output: Pirtobrutinib;Bendamustine;Idelalisib;Rituximab